APA (7th ed.) Citation

Verheyen, N., & März, W. (2017). Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial. Clinical chemistry and laboratory medicine, 55(7), . https://doi.org/10.1515/cclm-2016-1159

Chicago Style (17th ed.) Citation

Verheyen, Nicolas, and Winfried März. "Low-grade Inflammation and Tryptophan-kynurenine Pathway Activation Are Associated with Adverse Cardiac Remodeling in Primary Hyperparathyroidism: The EPATH Trial." Clinical Chemistry and Laboratory Medicine 55, no. 7 (2017). https://doi.org/10.1515/cclm-2016-1159.

MLA (9th ed.) Citation

Verheyen, Nicolas, and Winfried März. "Low-grade Inflammation and Tryptophan-kynurenine Pathway Activation Are Associated with Adverse Cardiac Remodeling in Primary Hyperparathyroidism: The EPATH Trial." Clinical Chemistry and Laboratory Medicine, vol. 55, no. 7, 2017, https://doi.org/10.1515/cclm-2016-1159.